Atlas Trials

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Clinical trial NCT02885324 · TERMINATED

Trial details

NCT number
NCT02885324
Sponsor
Indiana University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma MultiformeAnaplastic AstrocytomaMalignant Brain TumorHigh Grade Glioma
Start date
2017-05-18
Primary completion
2020-08-25
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.